Literature DB >> 30300140

Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.

Tae Hyun Kim1, Yoon Mee Yang1,2, Chang Yeob Han1,3, Ja Hyun Koo1, Hyunhee Oh4, Su Sung Kim4, Byoung Hoon You5, Young Hee Choi5, Tae-Sik Park6, Chang Ho Lee7, Hitoshi Kurose8, Mazen Noureddin9, Ekihiro Seki2, Yu-Jui Yvonne Wan10, Cheol Soo Choi4,11, Sang Geon Kim1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) arises from mitochondrial dysfunction under sustained imbalance between energy intake and expenditure, but the underlying mechanisms controlling mitochondrial respiration have not been entirely understood. Heterotrimeric G proteins converge with activated GPCRs to modulate cell-signaling pathways to maintain metabolic homeostasis. Here, we investigated the regulatory role of G protein α12 (Gα12) on hepatic lipid metabolism and whole-body energy expenditure in mice. Fasting increased Gα12 levels in mouse liver. Gα12 ablation markedly augmented fasting-induced hepatic fat accumulation. cDNA microarray analysis from Gna12-KO liver revealed that the Gα12-signaling pathway regulated sirtuin 1 (SIRT1) and PPARα, which are responsible for mitochondrial respiration. Defective induction of SIRT1 upon fasting was observed in the liver of Gna12-KO mice, which was reversed by lentivirus-mediated Gα12 overexpression in hepatocytes. Mechanistically, Gα12 stabilized SIRT1 protein through transcriptional induction of ubiquitin-specific peptidase 22 (USP22) via HIF-1α increase. Gα12 levels were markedly diminished in liver biopsies from NAFLD patients. Consistently, Gna12-KO mice fed a high-fat diet displayed greater susceptibility to diet-induced liver steatosis and obesity due to decrease in energy expenditure. Our results demonstrate that Gα12 regulates SIRT1-dependent mitochondrial respiration through HIF-1α-dependent USP22 induction, identifying Gα12 as an upstream molecule that contributes to the regulation of mitochondrial energy expenditure.

Entities:  

Keywords:  Fatty acid oxidation; G-proteins; Hepatology; Metabolism; Obesity

Mesh:

Substances:

Year:  2018        PMID: 30300140      PMCID: PMC6264648          DOI: 10.1172/JCI97831

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

Review 1.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

2.  A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells.

Authors:  N Xu; L Bradley; I Ambdukar; J S Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis.

Authors:  Patrick Kelly; Benjamin J Moeller; Juhi Juneja; Michelle A Booden; Channing J Der; Yehia Daaka; Mark W Dewhirst; Timothy A Fields; Patrick J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-16       Impact factor: 11.205

6.  Adipose tissue-specific inhibition of hypoxia-inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice.

Authors:  Xinmei Zhang; Karen S L Lam; Hongying Ye; Sookja K Chung; Mingyan Zhou; Yu Wang; Aimin Xu
Journal:  J Biol Chem       Date:  2010-08-16       Impact factor: 5.157

7.  Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo.

Authors:  Marius Grzelinski; Olaf Pinkenburg; Thomas Büch; Maike Gold; Stefanie Stohr; Hermann Kalwa; Thomas Gudermann; Achim Aigner
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

8.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

Review 9.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 10.  DNA replication stress: causes, resolution and disease.

Authors:  Abdelghani Mazouzi; Georgia Velimezi; Joanna I Loizou
Journal:  Exp Cell Res       Date:  2014-09-30       Impact factor: 3.905

View more
  16 in total

1.  Live cell optical assay for precise characterization of receptors coupling to Gα12.

Authors:  Ikuo Masuho; Nickolas K Skamangas; Kirill A Martemyanov
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-04-15       Impact factor: 4.080

2.  CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression.

Authors:  Z Yang; P Li; Q Shang; Y Wang; J He; S Ge; R Jia; X Fan
Journal:  Sci Adv       Date:  2020-11-27       Impact factor: 14.136

3.  USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis.

Authors:  Min Li; Yanqin Xu; Jie Liang; Hao Lin; Xinyue Qi; Fanlin Li; Ping Han; Yanfeng Gao; Xuanming Yang
Journal:  Mol Ther       Date:  2021-02-15       Impact factor: 12.910

Review 4.  Gα12/13 signaling in metabolic diseases.

Authors:  Yoon Mee Yang; Da-Sol Kuen; Yeonseok Chung; Hitoshi Kurose; Sang Geon Kim
Journal:  Exp Mol Med       Date:  2020-06-23       Impact factor: 8.718

5.  Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.

Authors:  Feng-Zhi Xin; Ze-Hua Zhao; Rui-Nan Zhang; Qin Pan; Zi-Zhen Gong; Chao Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

Review 6.  Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD.

Authors:  Takefumi Kimura; Sai P Pydi; Jonathan Pham; Naoki Tanaka
Journal:  Biomolecules       Date:  2020-10-15

Review 7.  Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35.

Authors:  Tezz Quon; Li-Chiung Lin; Amlan Ganguly; Andrew B Tobin; Graeme Milligan
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-29

Review 8.  G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment.

Authors:  Ming Yang; Chun-Ye Zhang
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

9.  Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases.

Authors:  Yun Seok Kim; Sang Geon Kim
Journal:  Clin Mol Hepatol       Date:  2020-09-22

Review 10.  Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical Options.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Healthcare (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.